A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis
- 9 January 2006
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 37 (4) , 353-358
Abstract
Systemic mastocytosis (SM) is a disease characterized by tissue infiltration of neoplastic mast cells originating from hematopoietic stem cells. Patients with advanced SM have a poor prognosis, and there is no mast cell ablative therapy available for most patients who carry an activating point mutation in the c-kit gene. We report results of a prospective study evaluating the safety, engraftment, and possibility of inducing a graft-versus-mast cell (GvMC) effect after allogeneic nonmyeloablative hematopoietic cell transplantation (HCT) from an HLA-identical sibling. Three patients with advanced SM were transplanted. All achieved complete donor T cell chimerism followed by clinical evidence for GvMC effect. However, all patients experienced disease progression with the longest response duration of 39 months. The GvMC effect can be observed after nonmyeloablative HCT with limited efficacy. Effective cytoreductive therapy prior to HCT may be required for long-term disease control and cure.Keywords
This publication has 30 references indexed in Scilit:
- Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantationBone Marrow Transplantation, 2004
- Systemic MastocytosisAnnual Review of Medicine, 2004
- Cladribine therapy for systemic mastocytosisBlood, 2003
- The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemiaBone Marrow Transplantation, 2003
- High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantationBone Marrow Transplantation, 2002
- Treatment of Systemic Mast-Cell Disease with CladribineNew England Journal of Medicine, 2001
- High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantationBone Marrow Transplantation, 2000
- Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty casesAmerican Journal of Hematology, 1998
- Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemiaBone Marrow Transplantation, 1998
- Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.Proceedings of the National Academy of Sciences, 1995